2/26
11:13 am
vrtx
Crispr Therapeutics gains amid takeover speculation [Seeking Alpha]
Low
Report
Crispr Therapeutics gains amid takeover speculation [Seeking Alpha]
2/26
11:05 am
vrtx
Is Vertex Stock Outperforming the Dow? [Yahoo! Finance]
Low
Report
Is Vertex Stock Outperforming the Dow? [Yahoo! Finance]
2/26
08:19 am
vrtx
TIME Reveals 2026 Women of the Year List Recognizing 16 Leaders Working Toward a More Equitable World [Yahoo! Finance]
Low
Report
TIME Reveals 2026 Women of the Year List Recognizing 16 Leaders Working Toward a More Equitable World [Yahoo! Finance]
2/26
07:59 am
vrtx
Physician-Scientist Reshma Kewalramani Runs One of Biotech's Biggest Companies [Yahoo! Finance]
Low
Report
Physician-Scientist Reshma Kewalramani Runs One of Biotech's Biggest Companies [Yahoo! Finance]
2/19
05:35 pm
vrtx
Is Vertex Pharmaceuticals (VRTX) Now Offering A Compelling Entry Point After Flat One Year Returns [Yahoo! Finance]
Low
Report
Is Vertex Pharmaceuticals (VRTX) Now Offering A Compelling Entry Point After Flat One Year Returns [Yahoo! Finance]
2/18
01:52 pm
vrtx
Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) [Seeking Alpha]
Low
Report
Vertex Pharmaceuticals Stock: Is The Bull Run Over (Rating Downgrade) [Seeking Alpha]
2/17
04:00 pm
vrtx
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
Low
Report
Vertex to Participate in TD Cowen 46th Annual Health Care Conference on March 3
2/17
02:31 pm
vrtx
Crispr: Emphasis Shifts To Cardiovascular Pipeline Amid Slow Casgevy Launch [Seeking Alpha]
Low
Report
Crispr: Emphasis Shifts To Cardiovascular Pipeline Amid Slow Casgevy Launch [Seeking Alpha]
2/17
10:04 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $441.00 price target on by analysts at Canaccord Genuity Group Inc..
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $441.00 price target on by analysts at Canaccord Genuity Group Inc..
2/17
08:10 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $591.00 price target on by analysts at HC Wainwright.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $591.00 price target on by analysts at HC Wainwright.
2/17
07:01 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/17
03:26 am
vrtx
Vertex Pharmaceuticals Stock: Is Wall Street Bullish or Bearish? [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals Stock: Is Wall Street Bullish or Bearish? [Yahoo! Finance]
2/13
01:05 pm
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/13
11:12 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Scotiabank.
2/13
11:12 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $541.00 price target on by analysts at Royal Bank Of Canada.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $541.00 price target on by analysts at Royal Bank Of Canada.
2/13
10:16 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
2/13
10:16 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
2/13
09:09 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $466.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was given a new $466.00 price target on by analysts at Stifel Nicolaus.
2/13
08:00 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $540.00 price target on the stock.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Oppenheimer Holdings, Inc. from a "market perform" rating to an "outperform" rating. They now have a $540.00 price target on the stock.
2/13
07:17 am
vrtx
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Vertex Pharmaceuticals (NASDAQ:VRTX) had its "buy" rating reaffirmed by analysts at HC Wainwright.
2/12
09:14 pm
vrtx
Vertex Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Vertex Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
2/12
04:21 pm
vrtx
Vertex Pharmaceuticals's (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue [Yahoo! Finance]
Medium
Report
Vertex Pharmaceuticals's (NASDAQ:VRTX) Q4 CY2025: Beats On Revenue [Yahoo! Finance]
2/12
04:11 pm
vrtx
Vertex Pharmaceuticals Non-GAAP EPS of $5.03 misses by $0.12, revenue of $3.19B beats by $20M [Seeking Alpha]
Medium
Report
Vertex Pharmaceuticals Non-GAAP EPS of $5.03 misses by $0.12, revenue of $3.19B beats by $20M [Seeking Alpha]
2/12
04:01 pm
vrtx
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
Medium
Report
Vertex Reports Fourth Quarter and Full Year 2025 Financial Results
2/10
10:19 pm
vrtx
Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect [Yahoo! Finance]
Low
Report
Vertex Pharmaceuticals (VRTX) Q4 Earnings: What To Expect [Yahoo! Finance]